Page last updated: 2024-11-06

thymidine and Acute Lymphoid Leukemia

thymidine has been researched along with Acute Lymphoid Leukemia in 20 studies

Research Excerpts

ExcerptRelevanceReference
" To further investigate this possible therapeutic approach we used a whole blood assay to characterize the proliferative responsiveness (3H-thymidine incorporation) of circulating T cells from AML patients with severe treatment-induced leukopenia, i."3.72Functional characterization of T lymphocytes derived from patients with acute myelogenous leukemia and chemotherapy-induced leukopenia. ( Bruserud, Ø; Ernst, P; Nesthus, I; Paulsen, K; Sjo, M; Wendelbo, Ø, 2004)
"Twenty patients who received high-dose methotrexate for osteosarcoma (n = 11), lymphoid cancers (n = 8), and gastric cancer (n = 1) developed nephrotoxicity (median serum creatinine, 3."3.69Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction. ( Adamson, PC; Balis, FM; Montello, MJ; Murphy, RF; O'Brien, M; Sorensen, JM; Widemann, BC, 1997)
"It is uncertain if acute lymphoblastic leukemia (ALL) cells expressing myeloid makers can respond to granulocyte colony-stimulating factor (G-CSF) and granulocyte macrophage colony-stimulating factor (GM-CSF)."2.68Heterogeneous effects of G-CSF and GM-CSF on cell growth and ara-C cytotoxicity in childhood leukemias which express myeloid markers. ( Cao, DC; Higashigawa, M; Hori, H; Ido, M; Kawasaki, H; Komada, Y; Kuwabara, H; Ohkubo, T; Sakurai, M, 1996)
"Acute lymphoblastic leukemia (ALL) with mixed lineage leukemia (MLL) gene rearrangements (MLL+ALL) has a dismal prognosis and is characterized by high surface CD44 expression."1.46Inflammatory mediator ultra-low-molecular-weight hyaluronan triggers necrosis of B-precursor leukemia cells with high surface CD44 expression. ( Abe, M; Ando, N; Furuichi, Y; Goi, K; Inukai, T; Kagami, K; Kasai, S; Nagano, O; Nakane, T; Ohno, S; Okazaki, S; Saitoh, S; Saya, H; Sugita, K, 2017)
"We show that acute lymphoblastic leukemia (ALL) cells avoid lethal replication stress after thymidine (dT)-induced inhibition of DNP dCTP synthesis by switching to NSP-mediated dCTP production."1.40Co-targeting of convergent nucleotide biosynthetic pathways for leukemia eradication. ( Armijo, AL; Austin, WR; Boulos, N; Campbell, DO; Czernin, J; Darvish, R; Dimitrova, E; Faull, KF; Gordin, A; Herschman, HR; Jung, ME; Lavie, A; Le, TM; Lee, JT; Li, Z; Liao, HI; Martin, C; Murphy, JM; Nathanson, DA; Nomme, J; Phelps, ME; Radu, CG; Sadeghi, S; Ta, L; Tom, M; Wei, L; Wilks, M, 2014)
"Neoplastic cells of childhood acute lymphoblastic leukemia (ALL) with natural killer (NK) cell properties were studied for the expression of p75 interleukin-2 receptors (IL-2R) and the receptor functions."1.28Functional p75 interleukin-2 receptor expression on the fresh blast cells in childhood acute lymphoblastic leukemia with natural killer cell properties. ( Ichikawa, M; Kawai, H; Kinoshita, A; Komiyama, A; Miyasaka, M; Nakazawa, S; Tsudo, M, 1991)
"Using JM and MOLT3, two human T-cell acute lymphoblastic leukemia cell lines, we investigated the ability of 24-h thymidine exposures to enhance the cytotoxicity of cis-diammine-1,1-cyclobutane dicarboxylate platinum (II) (carboplatin)."1.28Interactions of thymidine, hyperthermia, and cis-diammine-1,1-cyclobutane dicarboxylate platinum (II) in human T-cell leukemia. ( Cohen, JD; Robins, HI; Schmitt, CL; Tanner, MA, 1989)

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19901 (5.00)18.7374
1990's12 (60.00)18.2507
2000's5 (25.00)29.6817
2010's2 (10.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kasai, S1
Furuichi, Y1
Ando, N1
Kagami, K1
Abe, M1
Nakane, T1
Goi, K1
Inukai, T1
Saitoh, S1
Ohno, S1
Okazaki, S1
Nagano, O1
Saya, H1
Sugita, K1
Nathanson, DA1
Armijo, AL1
Tom, M1
Li, Z1
Dimitrova, E1
Austin, WR1
Nomme, J1
Campbell, DO1
Ta, L1
Le, TM1
Lee, JT1
Darvish, R1
Gordin, A1
Wei, L1
Liao, HI1
Wilks, M1
Martin, C1
Sadeghi, S1
Murphy, JM1
Boulos, N1
Phelps, ME1
Faull, KF1
Herschman, HR1
Jung, ME1
Czernin, J1
Lavie, A1
Radu, CG1
Hegazy, AN1
Klein, C1
Wendelbo, Ø1
Nesthus, I1
Sjo, M1
Paulsen, K1
Ernst, P1
Bruserud, Ø1
Roychowdhury, S1
Baiocchi, RA1
Vourganti, S1
Bhatt, D1
Blaser, BW1
Freud, AG1
Chou, J1
Chen, CS2
Xiao, JJ1
Parthun, M1
Chan, KK1
Eisenbeis, CF1
Ferketich, AK1
Grever, MR1
Caligiuri, MA1
Gangjee, A1
Devraj, R1
McGuire, JJ1
Kisliuk, RL1
Haber, M1
Norris, MD1
Kavallaris, M1
Camacho, M1
Madafiglio, J1
Baker, CJ1
White, L1
Stewart, BW2
Taskén, K2
Andersson, KB2
Erikstein, BK1
Hansson, V1
Jahnsen, T1
Blomhoff, HK2
Christoffersen, J1
Smeland, EB1
Stokke, T1
van der Plas, DC1
Smiers, F1
Pouwels, K2
Hoefsloot, LH1
Löwenberg, B2
Touw, IP2
Higashigawa, M1
Kuwabara, H1
Cao, DC1
Hori, H1
Ohkubo, T1
Kawasaki, H1
Ido, M1
Komada, Y1
Sakurai, M1
Widemann, BC1
Balis, FM1
Murphy, RF1
Sorensen, JM1
Montello, MJ1
O'Brien, M1
Adamson, PC1
Sackey, FN1
Watson, CS1
Gametchu, B1
Barnes, MJ1
Taylor, GA1
Newell, DR1
Jeanteur, P1
Ichikawa, M1
Kawai, H1
Komiyama, A1
Tsudo, M1
Miyasaka, M1
Kinoshita, A1
Nakazawa, S1
Catchpoole, D1
Bökkerink, JP1
Damen, FJ1
Hulscher, MW1
Bakker, MA1
De Abreu, RA1
van Agthoven, AJ1
van Gurp, R1
Delwel, R1
Hagemeijer, A1
Hählen, K1
Cohen, JD1
Robins, HI1
Schmitt, CL1
Tanner, MA1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Trial of Carboxypeptidase-G2 (CPDG2) and Thymidine for the Management of Patients With Methotrexate Toxicity and Renal Dysfunction[NCT00001298]Phase 110 participants Interventional1992-03-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for thymidine and Acute Lymphoid Leukemia

ArticleYear
Heterogeneous effects of G-CSF and GM-CSF on cell growth and ara-C cytotoxicity in childhood leukemias which express myeloid markers.
    Leukemia & lymphoma, 1996, Volume: 22, Issue:3-4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosylcytosine Triphosphate; C

1996

Other Studies

19 other studies available for thymidine and Acute Lymphoid Leukemia

ArticleYear
Inflammatory mediator ultra-low-molecular-weight hyaluronan triggers necrosis of B-precursor leukemia cells with high surface CD44 expression.
    Cell death & disease, 2017, 06-01, Volume: 8, Issue:6

    Topics: Biological Transport; Cell Line, Tumor; Cell Survival; Child; Child, Preschool; Female; Gene Express

2017
Co-targeting of convergent nucleotide biosynthetic pathways for leukemia eradication.
    The Journal of experimental medicine, 2014, Mar-10, Volume: 211, Issue:3

    Topics: Animals; Biosynthetic Pathways; Deoxycytidine Kinase; Deoxycytosine Nucleotides; Disease Eradication

2014
Ex vivo priming of CD4 T cells converts immunological tolerance into effective antitumor immunity in a murine model of acute lymphoblastic leukemia.
    Leukemia, 2008, Volume: 22, Issue:11

    Topics: Animals; CD4-Positive T-Lymphocytes; Cell Proliferation; Dendritic Cells; Disease Models, Animal; Fe

2008
Functional characterization of T lymphocytes derived from patients with acute myelogenous leukemia and chemotherapy-induced leukopenia.
    Cancer immunology, immunotherapy : CII, 2004, Volume: 53, Issue:8

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; CD28 Antigen

2004
Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
    Journal of the National Cancer Institute, 2004, Oct-06, Volume: 96, Issue:19

    Topics: Animals; Antineoplastic Agents; Apoptosis; Burkitt Lymphoma; Caspase Inhibitors; Cell Division; Cell

2004
Effect of bridge region variation on antifolate and antitumor activity of classical 5-substituted 2,4-diaminofuro[2,3-d]pyrimidines.
    Journal of medicinal chemistry, 1995, Sep-15, Volume: 38, Issue:19

    Topics: Antineoplastic Agents; Cell Division; Folic Acid; Folic Acid Antagonists; Humans; Hypoxanthine; Hypo

1995
An assay for the determination of reduced methotrexate accumulation in cells displaying limited viability in vitro.
    Cancer letters, 1995, Oct-20, Volume: 97, Issue:1

    Topics: Animals; Cryopreservation; Freezing; Methotrexate; Mice; Mice, Nude; Neoplasm Transplantation; Precu

1995
Regulation of growth in a neoplastic B cell line by transfected subunits of 3',5'-cyclic adenosine monophosphate-dependent protein kinase.
    Endocrinology, 1994, Volume: 135, Issue:5

    Topics: B-Lymphocytes; Blotting, Northern; Cell Division; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protei

1994
Retinoblastoma protein is rapidly dephosphorylated by elevated cyclic adenosine monophosphate levels in human B-lymphoid cells.
    Cancer research, 1994, Apr-15, Volume: 54, Issue:8

    Topics: B-Lymphocytes; Cell Cycle; Cell Division; Cell Line; Cell Nucleus; Colforsin; Cyclic AMP; Humans; Mi

1994
Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
    Leukemia, 1996, Volume: 10, Issue:8

    Topics: Animals; Antigens, CD; B-Lymphocytes; Base Sequence; Burkitt Lymphoma; Cell Line; DNA Primers; DNA-B

1996
Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:5

    Topics: Adolescent; Adult; Antidotes; Antimetabolites, Antineoplastic; Carboxypeptidases; Child; Child, Pres

1997
Cell cycle regulation of membrane glucocorticoid receptor in CCRF-CEM human ALL cells: correlation to apoptosis.
    The American journal of physiology, 1997, Volume: 273, Issue:3 Pt 1

    Topics: Apoptosis; Blotting, Western; Cell Cycle; Cell Membrane; Demecolcine; DNA, Neoplasm; G1 Phase; Gene

1997
Development of a whole cell assay to measure methotrexate-induced inhibition of thymidylate synthase and de novo purine synthesis in leukaemia cells.
    Biochemical pharmacology, 2000, Feb-15, Volume: 59, Issue:4

    Topics: Adenine; Antimetabolites, Antineoplastic; Child; Guanine; Humans; Inosine; Leukemia; Methotrexate; P

2000
[Nutrition, genetic polymorphism, and cancer].
    Bulletin du cancer, 2000, Volume: 87, Issue:2

    Topics: Colorectal Neoplasms; DNA; DNA Repair; Folic Acid; Genotype; Humans; Methylenetetrahydrofolate Reduc

2000
Functional p75 interleukin-2 receptor expression on the fresh blast cells in childhood acute lymphoblastic leukemia with natural killer cell properties.
    American journal of hematology, 1991, Volume: 36, Issue:4

    Topics: Adolescent; Antibodies, Monoclonal; Antigens, CD; Blast Crisis; Cell Division; Histocytochemistry; H

1991
Structural analysis of replicating DNA following exposure to cytotoxic drugs: implications for current models of DNA synthesis in mammalian cells.
    Anti-cancer drug design, 1990, Volume: 5, Issue:1

    Topics: Antineoplastic Agents; Cell Line; Chromatography, DEAE-Cellulose; DNA; DNA Replication; DNA, Single-

1990
Biochemical evidence for synergistic combination treatment with methotrexate and 6-mercaptopurine in acute lymphoblastic leukemia.
    Haematology and blood transfusion, 1990, Volume: 33

    Topics: Antineoplastic Combined Chemotherapy Protocols; DNA, Neoplasm; Drug Synergism; Humans; Lymphocytes;

1990
Role of interleukin-7 in the growth of acute lymphoblastic leukemia.
    Bone marrow transplantation, 1990, Volume: 6 Suppl 1

    Topics: Cell Division; DNA, Neoplasm; Humans; Interleukin-7; Precursor Cell Lymphoblastic Leukemia-Lymphoma;

1990
Interactions of thymidine, hyperthermia, and cis-diammine-1,1-cyclobutane dicarboxylate platinum (II) in human T-cell leukemia.
    Cancer research, 1989, Nov-01, Volume: 49, Issue:21

    Topics: Antineoplastic Agents; Carboplatin; Cell Line; Cell Survival; Drug Synergism; Heart; Humans; Organop

1989